| Sanofi India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500674 |
NSE Symbol : SANOFI |
P/E(TTM) : 22.37 |
|
ISIN Demat : INE058A01010 |
Div & Yield% : 3.69 |
EPS(TTM) : 148.84 |
|
Book Value(₹) : 358.68 |
Market Cap(₹Cr) : 7,668.53 |
Face Value(₹) : 10.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,837.40 | 2,013.20 | 2,851.10 | 2,770.10 | 2,956.60 |
| Other Income | 19.70 | 116.30 | 83.10 | 203.50 | 563.60 |
| Stock Adjustments | -136.80 | -60.20 | 292.40 | 11.10 | -43.10 |
| Total Income | 1,720.30 | 2,069.30 | 3,226.60 | 2,984.70 | 3,477.10 |
| EXPENDITURE : | |||||
| Raw Materials | 760.40 | 919.10 | 1,493.40 | 1,200.70 | 1,263.70 |
| Power and Fuel Cost | 14.60 | 11.60 | 14.60 | 14.30 | 13.90 |
| Other Manufacturing Expenses | 22.10 | 34.20 | 75.30 | 74.30 | 73.70 |
| Selling and Administration Expenses | 186.50 | 212.10 | 332.60 | 315.70 | 306.90 |
| Miscellaneous Expenses | 67.70 | 82.70 | 53.00 | 65.90 | 58.90 |
| Employee Benefit Expenses | 185.30 | 240.20 | 370.60 | 405.90 | 433.90 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 483.70 | 569.40 | 887.10 | 907.90 | 1,326.10 |
| Interest | 1.70 | 1.50 | 1.70 | 1.70 | 1.80 |
| Gross Profit | 482.00 | 567.90 | 885.40 | 906.20 | 1,324.30 |
| Depreciation | 37.30 | 36.70 | 39.60 | 41.90 | 66.70 |
| Profit Before Tax | 444.70 | 531.20 | 845.80 | 864.30 | 1,257.60 |
| Current Tax | 122.90 | 125.80 | 243.30 | 245.20 | 336.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -4.90 | -8.10 | -0.70 | -1.50 | -22.80 |
| Reported Net Profit | 326.70 | 413.50 | 603.20 | 620.60 | 944.40 |
| Extraordinary Items | -19.68 | -28.77 | 12.68 | 94.55 | 363.33 |
| Adjusted Net Profit | 346.38 | 442.27 | 590.52 | 526.05 | 581.07 |
| Adjustment below Net Profit | 1.70 | -185.00 | -1.30 | 0.50 | -3.30 |
| Profit/Loss Balance carried down | 445.80 | 601.90 | 843.20 | 1,795.10 | 1,694.60 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 442.20 | 384.60 | 843.20 | 1,573.00 | 840.60 |
| P & L Balance carried down | 332.00 | 445.80 | 601.90 | 843.20 | 1,795.10 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 1,230.00 | 1,170.00 | 1,670.00 | 5,700.00 | 4,900.00 |
| Dividend Per Share(Rs) | 123.00 | 117.00 | 167.00 | 570.00 | 490.00 |
| Earnings Per Share-Unit Curr | 142.04 | 179.78 | 262.26 | 269.83 | 410.61 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 325.74 | 374.17 | 441.52 | 554.70 | 967.65 |
| Book Value(Adj)-Unit Curr | 325.74 | 374.17 | 441.52 | 554.70 | 967.65 |
